Key market opportunities in the CDMO sector include rising outsourcing demands for biologics and HPAPIs, driven by R&D costs ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the contract development and manufacturing organization (CDMO) outsourcing market and it is poised to grow by USD 44.17 billion during 2020-2024, ...

The CDMO market offers growth opportunities via increasing demand for biologic therapies and strategic collaborations due to rising drug complexity and strong R&D funding. Challenges include supply ...

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing Organization (CMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been ...

Mordor Intelligence has published a new report on the Pharmaceutical Contract Manufacturing Organization (CMO) Market, offering a comprehensive analysis of trends, growth drivers, and future ...

Pluri, an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and Manufacturing Organization (CDMO) division ...

“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

The "mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Indication (Metabolic & Genetic Diseases), By Application, By End Use, By Region ...

DUBLIN--(BUSINESS WIRE)--The "Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market Growth Opportunities, 2023" report has been added to ResearchAndMarkets.com's ...

Outsourcing offers expertise beyond facilities, but sponsors need strategic CDMO partnerships for peptide therapeutics, cell ...

HAIFA, Israel, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote global ...